Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis 2020-04-09 15:14
Yuyu Pharma appoints Robert Wonsang Yu as incoming President and CEO 2020-04-06 08:00
Yuyu Pharma introduces enhanced ERP system 2020-03-31 21:00
Fosun Pharma Announces 2019 Annual Results 2020-03-31 17:51
3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2% 2020-03-31 12:29
Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China 2020-03-30 19:00
Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development 2020-03-30 08:00
GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial 2020-03-27 21:00
Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib) 2020-03-27 19:00
Luye Pharma Continues to Deliver Strong Growth in 2019 2020-03-27 16:44
CStone submits new drug application for the targeted therapy avapritinib in Taiwan for the treatment of adults with advanced PDGFRA exon 18 mutant gastrointestinal stromal tumor 2020-03-27 14:02
Fosun Pharma's Novel Coronavirus Nucleic Acid Detection Kit Receives Emergency Approval from China NMPA 2020-03-26 22:27
Bio-Pharm Solutions Expands from Epilepsy to Neurodegenerative Diseases Aiming for IPO 2020-03-26 21:00
Happiness Biotech Announced Breakthrough in Developing Covid-19 Testing Kits 2020-03-25 20:00
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted 2020-03-24 19:25
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States 2020-03-24 12:30
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States 2020-03-24 12:24
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States 2020-03-23 19:00
ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai 2020-03-17 23:07
Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate 2020-03-17 08:04
1 121 122 123 124 125 165